Instil Bio, Inc. 8-K

What Happened Instil Bio, Inc. (filed 8-K on June 11, 2026) held its 2026 Annual Meeting of Stockholders on June 11, 2026. Stockholders elected two Class II directors (George Matcham and Neil Gibson) to serve until the 2029 annual meeting and ratified the Audit Committee’s selection of RSM US LLP as the company’s independent registered public accounting firm for fiscal 2026.

Key Details

• Shares: 6,781,976 shares outstanding as of the record date; 5,757,919 shares (≈84.9%) were present or represented by proxy.
• Director votes:
  • George Matcham — For: 3,683,114; Withheld: 742,925; Broker non‑votes: 1,331,880.
  • Neil Gibson — For: 3,603,901; Withheld: 822,138; Broker non‑votes: 1,331,880.
• Auditor ratification: RSM US LLP — For: 5,750,869; Against: 6,911; Abstentions: 139.

Why It Matters These results confirm board continuity and leadership through the 2029 annual meeting, which matters for ongoing strategy and oversight. Ratification of RSM US LLP keeps the company’s auditing relationship in place for fiscal 2026, affecting financial reporting and controls. The reported broker non‑votes show a portion of shares were not voted by brokers, which can influence the final vote tallies but did not prevent election of the nominees or auditor ratification in this meeting.